TNDM (Tandem Diabetes Care, Inc.) Stock Financials & Earnings | Market Cap Arena

TNDM (Tandem Diabetes Care, Inc.) Stock Financials & Earnings | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

Mkt Cap$1B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.0B

Net Income (TTM)-$205M

EPS (TTM)-$3.07

Free Cash Flow (TTM)-$30M

Gross Margin53.8%

Op. Margin-18.2%

Net Margin-20.2%

FCF Margin-2.9%

P/S Ratio (TTM)1.5x

P/E Ratio (TTM)—

YoY Rev Growth-4.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$169M	$83M	-$128M
Q2 23	$196M	$102M	-$39M
Q3 23	$186M	$90M	-$32M
Q4 23	$197M	$93M	-$35M
Q1 24	$192M	$95M	-$42M
Q2 24	$222M	$113M	-$31M
Q3 24	$363M	$125M	-$26M
Q4 24	$283M	$157M	-$582K
Q1 25	$234M	$118M	-$121M
Q2 25	$241M	$126M	-$52M
Q3 25	$249M	$134M	-$20M
Q4 25	$290M	$167M	$8M

Valuation

Quarter	P/S	P/E
Q1 23	1.9x	—
Q2 23	1.9x	—
Q3 23	1.9x	—
Q4 23	2.0x	—
Q1 24	1.9x	—
Q2 24	1.9x	—
Q3 24	1.5x	—
Q4 24	1.4x	—
Q1 25	1.3x	—
Q2 25	1.3x	—
Q3 25	1.5x	—
Q4 25	1.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$18M	-$29M
Q2 23	-$6M	-$14M
Q3 23	$55K	-$5M
Q4 23	-$7M	-$35M
Q1 24	-$8M	-$12M
Q2 24	-$5M	-$12M
Q3 24	$27M	$22M
Q4 24	$11M	$8M
Q1 25	-$18M	-$21M
Q2 25	-$9M	-$16M
Q3 25	$8M	$4M
Q4 25	$10M	$3M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$11M
Q2 23	$8M
Q3 23	$5M
Q4 23	$27M
Q1 24	$4M
Q2 24	$6M
Q3 24	$5M
Q4 24	$3M
Q1 25	$3M
Q2 25	$6M
Q3 25	$4M
Q4 25	$7M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-3.7%	+55.4%
Q2 23	-2.2%	+10.5%
Q3 23	-9.3%	-13.8%
Q4 23	-10.8%	-2.7%
Q1 24	+13.2%	-21.5%
Q2 24	+13.3%	+7.7%
Q3 24	+95.7%	+79.3%
Q4 24	+43.6%	+22.2%
Q1 25	+22.3%	+52.3%
Q2 25	+8.5%	+15.8%
Q3 25	-31.4%	-30.8%
Q4 25	+2.7%	-0.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$21M	12.5%
Q2 23	$23M	11.9%
Q3 23	$21M	11.2%
Q4 23	$23M	11.6%
Q1 24	$22M	11.5%
Q2 24	$25M	11.2%
Q3 24	$26M	7.2%
Q4 24	$28M	10.0%
Q1 25	$25M	10.9%
Q2 25	$26M	10.7%
Q3 25	$21M	8.5%
Q4 25	$20M	6.9%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$121M	$90M
Q2 23	$43M	$98M
Q3 23	$42M	$79M
Q4 23	$43M	$86M
Q1 24	$46M	$90M
Q2 24	$49M	$94M
Q3 24	$51M	$100M
Q4 24	$52M	$106M
Q1 25	$125M	$114M
Q2 25	$48M	$110M
Q3 25	$48M	$106M
Q4 25	$46M	$113M

Revenue Segments

Quarter	Pump	Supplies and Other
Q1 24	$87M	$106M
Q2 24	$108M	$114M
Q1 25	$102M	$132M
Q2 25	$112M	$129M
Q3 25	$110M	$139M
Q4 25	$140M	$150M

Revenue by Geography

Quarter	Non-US	United States
Q1 23	$38M	$131M
Q2 23	$53M	$143M
Q3 23	$55M	$130M
Q4 23	$46M	$151M
Q1 24	$62M	$130M
Q2 24	$65M	$157M
Q4 24	$68M	$215M
Q1 25	$84M	$151M
Q2 25	$70M	$170M
Q3 25	$74M	$176M
Q4 25	$80M	$210M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$128M	$392M	$520M
Q2 23	$131M	$376M	$507M
Q3 23	$80M	$419M	$498M
Q4 23	$59M	$409M	$468M
Q1 24	$59M	$409M	$468M
Q2 24	$48M	$405M	$452M
Q3 24	$49M	$424M	$473M
Q4 24	$69M	$369M	$438M
Q1 25	$54M	$315M	$369M
Q2 25	$64M	$251M	$315M
Q3 25	$92M	$227M	$319M
Q4 25	$91M	$202M	$293M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	65M	+0.3%
Q2 23	65M	+0.4%
Q3 23	65M	+0.4%
Q4 23	65M	+0.4%
Q1 24	65M	-0.1%
Q2 24	65M	-0.5%
Q3 24	66M	+0.8%
Q4 24	66M	+0.9%
Q1 25	66M	+0.4%
Q2 25	67M	+1.0%
Q3 25	68M	+0.9%
Q4 25	68M	+0.5%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$114K	437
FY 15	$151K	482
FY 16	$143K	591
FY 17	$187K	574
FY 18	$282K	653
FY 19	$347K	1K
FY 20	$333K	2K
FY 21	$351K	2K
FY 22	$308K	3K
FY 23	$312K	2K
FY 24	$355K	3K
FY 25	$2K	500K